Literature DB >> 8246255

Purification and characterisation of haemagglutinin from Bordetella bronchiseptica.

Y Sakurai1, H Suzuki, E Terada.   

Abstract

A surface protein of Bordetella bronchiseptica was purified in one step by affinity chromatography with bovine submaxillary mucin coupled to agarose. The purified protein, with a mol. wt of 200 kDa and an iso-electric point of pI 6.5, showed haemagglutinating activity for bovine erythrocytes. This haemagglutinin (HA) inhibited the adherence of B. bronchiseptica to a rat lung cell line (L2) and was able to bind to N-acetylneuraminic acid. These findings suggest that the HA of B. bronchiseptica is an adhesin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8246255     DOI: 10.1099/00222615-39-5-388

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Bordetella bronchiseptica adherence to cilia is mediated by multiple adhesin factors and blocked by surfactant protein A.

Authors:  Jessica A Edwards; Nathan A Groathouse; Scott Boitano
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 2.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Reduced virulence of a Bordetella bronchiseptica siderophore mutant in neonatal swine.

Authors:  K B Register; T F Ducey; S L Brockmeier; D W Dyer
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica.

Authors:  Zhanqin Zhao; Yun Xue; Bin Wu; Xibiao Tang; Ruiming Hu; Yindi Xu; Aizhen Guo; Huanchun Chen
Journal:  Infect Immun       Date:  2008-02-11       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.